Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Upgrade Price Targets for Palantir Technologies Ahead of AIPCon Event

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Cyber-security-technology
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Mizuho has increased its price target for Palantir Technologies to $21 in anticipation of the company’s AIPCon event in March 2024. This adjustment signifies a more optimistic view on the company’s potential performance. Various analysts have offered different price targets for Palantir Technologies, with projections ranging from $17.54 to $30.00. Jefferies also upgraded Palantir’s stock rating from “underperform” to “hold,” setting a price target of $22 per share, demonstrating a rising confidence in the company’s future growth opportunities.

Palantir Technologies Inc. (PLTR) Shows Strong Performance in Stock Market on March 7, 2024

On March 7, 2024, Palantir Technologies Inc. (PLTR) saw a strong performance in the stock market, with the price of its shares increasing by $0.57, or 2.16%, since the previous market close. The stock opened at $26.91, which was $0.75 higher than its previous close, indicating a positive start to the trading day.

PLTR is currently trading near the top of its 52-week range and above its 200-day simple moving average, suggesting that the stock has been performing well in the long term.

The price momentum of PLTR on March 7th reflects investor confidence in the company and its future prospects. The increase in share price and the positive opening indicate that investors are optimistic about the company’s performance and potential for growth.

Overall, the performance of PLTR on March 7th was strong, with the stock showing positive price momentum and opening higher than its previous close. Investors will be keeping an eye on PLTR’s future performance to see if it can continue its upward trend and deliver strong returns in the long term.

Palantir Technologies (PLTR) Reports Impressive Financial Performance in Q4 2024

Palantir Technologies (PLTR) has been making waves in the tech industry with its data analytics and software solutions. The company’s recent financial performance has been impressive, with total revenue reaching $2.23 billion over the past year and $608.35 million in the fourth quarter alone. Compared to the previous year, total revenue has increased by 16.75%, showcasing the company’s growth and ability to attract new clients. Net income for Palantir Technologies has also seen significant growth, reaching $209.82 million over the past year and $93.39 million in the fourth quarter. Earnings per share (EPS) for PLTR stock have also shown positive growth, with EPS reaching $0.09 over the past year and $0.04 in the fourth quarter. Overall, Palantir Technologies’ stock performance on March 7, 2024, appears to be strong, with impressive growth in total revenue, net income, and earnings per share. Investors may view these financial metrics as positive indicators of the company’s potential for future growth and success in the competitive tech industry.

Tags: PLTR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare cloud based

Analyst Reaffirms Neutral Rating for Orthofix Medical with Increased Price Target

The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation

Intels Strategic Expansion Securing Government Grants for Military Chip Production and AI Development

SherwinWilliams Receives Upgrade from UBS Poised for Growth in US Housing Market

Recommended

Camping World Stock

Can Camping World Maintain Its Dividend Amid Market Pressures?

5 months ago
Trinity Biotech Stock

Trinity Biotech Faces Critical Nasdaq Compliance Deadline

5 months ago
DVY stock news

Amarin Strengthens Position and Maximizes Shareholder Value Through Share Repurchase Agreement with Cantor Fitzgerald

2 years ago
ASTeMobile Stock

ASTeMobile Shares Face Mounting Pressure as Investor Confidence Wanes

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Trending

Cassava Sciences Stock
Analysis

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

by Jackson Burston
February 8, 2026
0

The future of Cassava Sciences appears uncertain following the definitive termination of its Alzheimer's disease program. Detailed...

DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays
  • DroneShield Shares Face Headwinds Despite Record Performance
  • Rock Tech Lithium: Investors Await the Final Go-Ahead

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com